AddLife AB

ALIF B

SE0014401378

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe Other stock markets 02:40:04 21/01/2026 pm IST			5-day change	1st Jan Change
145.25 ^SEK	-0.45%		-6.19%	-8.61%

15/01	DNB Carnegie Lowers Target Price for Addlife to 170 Kronor (204), Reiterates Hold	FW
14/01	Indecap Sverige Rises 1.55 Percent in December - Strong Performance for Boliden	FW

DNB Carnegie Raises Target Price for Addlife to 204 SEK (190), Reiterates Hold

Published on 10/24/2025 at 11:09 am IST

Finwire - Translated by Marketscreener - See original

ADDLIFE AB

-0.45%

DNB Carnegie has increased its target price for Addlife to 204 SEK from the previous 190 SEK, while maintaining its "hold" recommendation.

DNB Carnegie has raised the target price for Addlife to 204 SEK (previously 190 SEK), and reiterates its hold rating.

Latest news about AddLife AB

15/01	DNB Carnegie Lowers Target Price for Addlife to 170 Kronor (204), Reiterates Hold	FW
14/01	Indecap Sverige Rises 1.55 Percent in December - Strong Performance for Boliden	FW
09/01	Norron Nordic Multi Strategy Rises 1.15 Percent in December – Positive Contributions from Fasadgruppen, Wall to Wall, and Bravida	FW
09/01	Norron Sustainable Equity up 2.08 Percent in December – Divests Munters and Reduces Position in ABB	FW
02/01	Fidelity Falls Below Five Percent Threshold in Addlife	FW
23/12	Handelsbanken Lowers Target Price for Addlife to 170 Kronor (220), Reiterates Hold - BN	FW
18/12	Addlife Drops After Target Price Cuts - Records Worst Trading Day Since July	FW
18/12	Nordea Lowers Target Price for Addlife to 213 Kronor (223), Reiterates Buy	FW
18/12	SEB Lowers Price Target for Addlife to 175 Kronor (205), Reiterates Hold	FW
08/12	Addlife CFO Christina Rubenhag Increases Her Shareholding	FW
05/12	Addlife CEO Fredrik Dalborg Expands Portfolio with Additional Shares	FW
01/12	Addlife acquires Opitek International	RE
01/12	Addlife Acquires Danish Firm Opitek to Bolster Patient Positioning Offerings	FW
01/12	Addlife Acquires Danish Company	FW
01/12	Addlife acquires Pharmacold	RE
01/12	Addlife Acquires Danish Firm Pharmacold to Bolster Service Business	FW
01/12	Addlife acquires Pharmacold	FW
25/11	Addlife Board Member Kristina Patek Makes Her First Share Purchase	FW
14/11	SEB Fonder reduces its stake in Addlife to below 10 percent	FW
13/11	Lannebo Health and New Technology Fund Down 0.2 Percent in October - Positive Contributions from Addlife, Sobi, and Getinge	FW
06/11	Cliens Small & Micro Cap Rises 5.5 Percent in October - Strong Month for Quality Companies	FW
06/11	Cliens Småbolag Rises 6.2 Percent in October--Increases Holdings in Balder and Sagax	FW
06/11	Cliens Sverige Rises 4.4% in October, Adds Verisure to Portfolio	FW
04/11	Fidelity increases its stake in Addlife	FW
24/25/24	Nordea raises its target price for Addlife to SEK 223 (207), reiterates buy recommendation	FW

AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.

Employees

2,327

Sector

Medical Equipment, Supplies & Distribution

Calendar

04/02 - Q4 2025 Earnings Release

More about the company